Evidence map›Paper›PMID 31983161›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.

Maryam Nazar, Iram Naz, Muhammad Khurram Mahmood, Shoaib Naiyer Hashmi

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Maryam NazarDepartment of Oral Pathology, Margalla Institute of Health Science, Rawalpindi, Pakistan.
Iram NazDepartment of Oral Pathology, Islamabad Medical and Dental College, Islamabad, Pakistan.
Muhammad Khurram MahmoodDepartment of Pharmacology and Therapeutics, HBS Medical and Dental College, Islamabad, Pakistan.
Shoaib Naiyer HashmiDepartment of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan.
Armed Forces Institute of Pathology · PKJinnah Medical & Dental College · PKKarachi Medical and Dental College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of current study was to investigate the expression of Cyclin D1 and Ki-67 in primary and metastatic oral squamous cell carcinoma (OSCC) and their different histological grades.

methodsParaffin embedded 30 oral squamous cell carcinoma (15 each of primary and cervical lymph node metastatic OSCC) were included in the study. Cyclin D1 and Ki 67 expressions were evaluated by immunohistochemistry and compared in primary and lymph node metastasis of OSCC and their histological grades. The data was analyzed using SPSS software.

resultsThe mean age of patients with primary OSCC was 53.47 ±16.67 years and 61.47 ±11.94 years in patients with metastasis. Males were comparatively affected more than females with tongue as the most common site involved in both primary and metastatic tumours. The mean size of primary and metastatic tumour biopsies were 1.16 mm and 3.93 mm respectively. Comparison of the expression of Cyclin D1 in these primary and metastatic OSCC revealed a statistically significant difference (p = 0.003) whereas it was insignificant for Ki-67 (p = 0.715).

conclusionCyclin D1 can be a useful marker in predicting aggressive or metastatic behaviour of OSCC on premier biopsies.

Indexed as

Biomarkers, TumorCarcinoma, Squamous CellCyclin D1FemaleHumansImmunohistochemistryKi-67 AntigenLymphatic MetastasisLymph NodesMaleMiddle AgedMouth NeoplasmsPrognosisRetrospective StudiesBiomarkers, TumorCCND1 protein, humanCyclin D1Ki-67 AntigenCyclin D1Ki-67MetastasisSquamous Cell Carcinoma

Identifiers

PMID31983161
PMCPMC7294039
OpenAlexW3003849505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.